Bio-Techne (TECH) Non-Current Deferred Tax Liability (2011 - 2026)

Bio-Techne's Non-Current Deferred Tax Liability history runs 16 years deep, the most recent figure standing at $14.2 million for Q1 2026.

• On a quarterly basis, Non-Current Deferred Tax Liability fell 55.49% year-over-year to $14.2 million in Q1 2026; TTM through Mar 2026 was $14.2 million, a 55.49% decrease from a year earlier, with the FY2025 full-year figure at $6.2 million, down 88.96% from the prior year.
• Non-Current Deferred Tax Liability rose to $14.2 million in Q1 2026 per TECH's latest filing, from $11.0 million in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $112.9 million in Q3 2022 and bottomed at $4.1 million in Q3 2023.
• The 5-year median for Non-Current Deferred Tax Liability is $55.9 million (2024), against an average of $56.7 million.
• Across the five-year window, Non-Current Deferred Tax Liability plunged 96.37% in 2023 and jumped 1119.93% in 2024, its largest moves.
• Year by year, Non-Current Deferred Tax Liability stood at $111.4 million in 2022, then slumped by 35.74% to $71.6 million in 2023, then plunged by 47.3% to $37.7 million in 2024, then plunged by 70.78% to $11.0 million in 2025, then rose by 28.94% to $14.2 million in 2026.
• Per Business Quant, the three latest TECH Non-Current Deferred Tax Liability figures stand at $14.2 million (Q1 2026), $11.0 million (Q4 2025), and $11.3 million (Q3 2025).